S&P 500   3,327.90 (-0.05%)
DOW   29,315.33 (-0.11%)
QQQ   223.72 (+0.15%)
AAPL   318.78 (+0.02%)
FB   221.05 (-0.49%)
MSFT   167.89 (+0.47%)
GOOGL   1,480.94 (+0.10%)
AMZN   1,873.33 (+0.46%)
CGC   24.77 (-0.48%)
NVDA   249.00 (-0.11%)
BABA   222.14 (-2.33%)
MU   58.45 (+1.37%)
GE   11.67 (-1.19%)
TSLA   544.78 (+6.71%)
AMD   51.59 (+1.30%)
T   38.46 (+0.18%)
ACB   2.07 (-2.82%)
F   9.12 (-0.44%)
NFLX   337.56 (-0.62%)
BAC   34.41 (-0.86%)
GILD   62.77 (-0.33%)
DIS   143.52 (-0.56%)
S&P 500   3,327.90 (-0.05%)
DOW   29,315.33 (-0.11%)
QQQ   223.72 (+0.15%)
AAPL   318.78 (+0.02%)
FB   221.05 (-0.49%)
MSFT   167.89 (+0.47%)
GOOGL   1,480.94 (+0.10%)
AMZN   1,873.33 (+0.46%)
CGC   24.77 (-0.48%)
NVDA   249.00 (-0.11%)
BABA   222.14 (-2.33%)
MU   58.45 (+1.37%)
GE   11.67 (-1.19%)
TSLA   544.78 (+6.71%)
AMD   51.59 (+1.30%)
T   38.46 (+0.18%)
ACB   2.07 (-2.82%)
F   9.12 (-0.44%)
NFLX   337.56 (-0.62%)
BAC   34.41 (-0.86%)
GILD   62.77 (-0.33%)
DIS   143.52 (-0.56%)
S&P 500   3,327.90 (-0.05%)
DOW   29,315.33 (-0.11%)
QQQ   223.72 (+0.15%)
AAPL   318.78 (+0.02%)
FB   221.05 (-0.49%)
MSFT   167.89 (+0.47%)
GOOGL   1,480.94 (+0.10%)
AMZN   1,873.33 (+0.46%)
CGC   24.77 (-0.48%)
NVDA   249.00 (-0.11%)
BABA   222.14 (-2.33%)
MU   58.45 (+1.37%)
GE   11.67 (-1.19%)
TSLA   544.78 (+6.71%)
AMD   51.59 (+1.30%)
T   38.46 (+0.18%)
ACB   2.07 (-2.82%)
F   9.12 (-0.44%)
NFLX   337.56 (-0.62%)
BAC   34.41 (-0.86%)
GILD   62.77 (-0.33%)
DIS   143.52 (-0.56%)
S&P 500   3,327.90 (-0.05%)
DOW   29,315.33 (-0.11%)
QQQ   223.72 (+0.15%)
AAPL   318.78 (+0.02%)
FB   221.05 (-0.49%)
MSFT   167.89 (+0.47%)
GOOGL   1,480.94 (+0.10%)
AMZN   1,873.33 (+0.46%)
CGC   24.77 (-0.48%)
NVDA   249.00 (-0.11%)
BABA   222.14 (-2.33%)
MU   58.45 (+1.37%)
GE   11.67 (-1.19%)
TSLA   544.78 (+6.71%)
AMD   51.59 (+1.30%)
T   38.46 (+0.18%)
ACB   2.07 (-2.82%)
F   9.12 (-0.44%)
NFLX   337.56 (-0.62%)
BAC   34.41 (-0.86%)
GILD   62.77 (-0.33%)
DIS   143.52 (-0.56%)
Log in

Voyager Therapeutics Price Target & Analyst Ratings (NASDAQ:VYGR)

$13.20
-0.59 (-4.28 %)
(As of 01/21/2020 11:49 AM ET)
Today's Range
$13.15
Now: $13.20
$13.79
50-Day Range
$13.31
MA: $13.90
$14.98
52-Week Range
$7.76
Now: $13.20
$28.79
Volume115,047 shs
Average Volume284,914 shs
Market Capitalization$489.32 million
P/E RatioN/A
Dividend YieldN/A
Beta2.47

Analyst Ratings

Voyager Therapeutics (NASDAQ:VYGR) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
7 Wall Street analysts have issued ratings and price targets for Voyager Therapeutics in the last 12 months. Their average twelve-month price target is $28.33, suggesting that the stock has a possible upside of 114.65%. The high price target for VYGR is $37.00 and the low price target for VYGR is $18.00. There are currently 2 hold ratings and 5 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.712.672.782.78
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $28.33$27.57$28.86$28.57
Price Target Upside: 114.65% upside93.35% upside87.44% upside10.36% upside

Voyager Therapeutics (NASDAQ:VYGR) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

(Ad)


2020 could be a monster year for cannabis stocks, especially with cannabis on many November ballots, and presidential candidates pushing for approval. In our latest special report, we detail five must-own cannabis stocks that could double, even triple your investment over the next year.

Voyager Therapeutics (NASDAQ:VYGR) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/24/2019Evercore ISIReiterated RatingHold$18.00Medium
11/6/2019WedbushReiterated RatingOutperformMedium
11/6/2019CowenReiterated RatingBuyHigh
10/11/2019Morgan StanleyLower Price TargetEqual Weight$28.00 ➝ $26.00Low
8/13/2019NomuraReiterated RatingBuy$37.00High
8/12/2019HC WainwrightReiterated RatingBuy$26.00Medium
3/5/2019Cantor FitzgeraldInitiated CoverageOverweight$27.00High
1/10/2019Chardan CapitalReiterated RatingNeutralMedium
1/8/2019BTIG ResearchLower Price TargetBuy ➝ Positive$23.00Low
11/8/2018Robert W. BairdLower Price TargetOutperform ➝ Outperform$31.00 ➝ $27.00High
7/17/2018Canaccord GenuityReiterated RatingBuy$31.00High
3/12/2018Piper Jaffray CompaniesReiterated RatingOverweight ➝ Buy$40.00High
(Data available from 1/21/2018 forward)
This page was last updated on 1/21/2020 by MarketBeat.com Staff

Featured Article: What is a Swap?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel